Next Post

Why Clovis Oncology Stock Trounced the Market Today

What happened Clovis Oncology (CLVS -3.00%) had a good Tuesday, with its share cost rising by almost 5% to defeat the functionality of quite a few other biotech shares, not to mention the S&P 500 index. A new offer announced by a partner of the corporation that will, ideally, advance […]